| 摘要 |
PROBLEM TO BE SOLVED: To provide a pharmaceutical formulation which is used for preventing, advancement-retarding, or treating diabetes, such as type 2 diabetes, or which is used for ameliorating microdose alubuminuria. SOLUTION: The pharmaceutical formulation comprises, as an active ingredient, valsartan which is used as angiotensin II(AT<SB>1</SB>) receptor antagonist. Valsartan is represented by (-)-N-ä4-[2-(1H-Tetrazol-5-yl)phenyl]benzyl}-N-valeryl-L-valine. COPYRIGHT: (C)2010,JPO&INPIT
|
